Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
Titel:
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
Auteur:
Knop, Filip K Aroda, Vanita R do Vale, Ruben D Holst-Hansen, Thomas Laursen, Peter N Rosenstock, Julio Rubino, Domenica M Garvey, W Timothy